The mission of the Chicago Biomedical Consortium is to stimulate collaboration among scientists at Northwestern University, the University of Chicago, and the University of Illinois Chicago that will transform research at the frontiers of biomedicine. The CBC will:
>> Stimulate research and education that bridge institutional boundaries.
>> Enable collaborative and interdisciplinary research that is beyond the range of a single institution.
>> Recruit and retain a strong cadre of biomedical leaders and researchers in Chicago.
>> Promote the development of the biomedical industry in Chicago.
>> Execute a plan capable of improving the health of citizens of Chicago and beyond.
The CBC gratefully acknowledges support from the Searle Funds at The Chicago Community Trust.
Company Details
- Employees
- 29
- Founded
- -
- Address
- 2205 Tech Dr., Cook 3133, Evanston,il 60208,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- San Francisco.
- HQ
- Evanston, IL
Chicago Biomedical Consortium Questions
Chicago Biomedical Consortium's website is https://chicagobiomedicalconsortium.org/
Chicago Biomedical Consortium's LinkedIn profile is https://www.linkedin.com/company/chibiomed
Chicago Biomedical Consortium has
29 employees.
View email and phone details for 29
employees at Chicago Biomedical Consortium.
Chicago Biomedical Consortium's industry is
Biotechnology Research
Chicago Biomedical Consortium's top competitors are
Fulton Labs,
Circ Biosciences,
Grove Biopharma, Inc.,
Paragon Biosciences,
Clostrabio, Inc,
Evozyne,
Vanqua Bio,
Chan Zuckerberg Biohub Network,
Portal Innovations,
Illinois Biotechnology Innovation Organization (Ibio).
Chicago Biomedical Consortium's categories are Biotechnology Research
Chicago Biomedical Consortium's founding year is 2001
